{"count": 5, "results": [{"_id": "32761160", "pmid": 32761160, "pmcid": "PMC7411539", "title": "Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment", "journal": "JAMA Netw Open", "authors": ["Hajjar I", "Okafor M", "McDaniel D", "Obideen M", "Dee E", "Shokouhi M", "Quyyumi AA", "Levey A", "Goldstein F"], "date": "2020-08-03T00:00:00Z", "doi": "10.1001/jamanetworkopen.2020.12252", "meta_date_publication": "2020 Aug 3", "meta_volume": "3", "meta_issue": "8", "meta_pages": "e2012252", "score": 50283.56, "text_hl": "Effects of @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@Candesartan@@@ vs @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ on Neurocognitive Function in Older Adults With Executive Mild @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@Cognitive Impairment@@@", "citations": {"NLM": "Hajjar I, Okafor M, McDaniel D, Obideen M, Dee E, Shokouhi M, Quyyumi AA, Levey A, Goldstein F. Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment JAMA Netw Open. 2020 Aug 3;3(8):e2012252. PMID: 32761160", "BibTeX": "@article{32761160, title={Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment}, author={Hajjar I and Okafor M and McDaniel D and Obideen M and Dee E and Shokouhi M and Quyyumi AA and Levey A and Goldstein F}, journal={JAMA Netw Open}, volume={3}, number={8}, pages={e2012252}}"}}, {"_id": "35916128", "pmid": 35916128, "title": "Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial.", "journal": "Hypertension", "authors": ["Rogers SC", "Ko YA", "Quyyumi AA", "Hajjar I"], "date": "2022-10-01T00:00:00Z", "doi": "10.1161/HYPERTENSIONAHA.122.19105", "meta_date_publication": "2022 Oct", "meta_volume": "79", "meta_issue": "10", "meta_pages": "2316-2327", "score": 50247.664, "text_hl": "METHODS: In 141 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ participants with mild @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive impairment@@@ (age 65.9+-7.7, 57% female), @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ (up to 32 mg, n=77) or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (up to 40 mg, n=64) were administered to achieve blood @DISEASE_Pressure_Ulcer @DISEASE_MESH:D003668 @@@pressure@@@ <140/90 mm Hg. ", "citations": {"NLM": "Rogers SC, Ko YA, Quyyumi AA, Hajjar I. Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial. Hypertension. 2022 Oct;79(10):2316-2327. PMID: 35916128", "BibTeX": "@article{35916128, title={Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial.}, author={Rogers SC and Ko YA and Quyyumi AA and Hajjar I}, journal={Hypertension}, volume={79}, number={10}, pages={2316-2327}}"}}, {"_id": "33849417", "pmid": 33849417, "title": "Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.", "journal": "Kardiologiia", "authors": ["Agarkov NM", "Okhotnikov OI", "Korneeva SI", "Moskaleva EO", "Moskalev AA", "Kolomiets VI", "Markelova AM", "Markelova EA"], "date": "2021-03-30T00:00:00Z", "doi": "10.18087/cardio.2021.3.n1509", "meta_date_publication": "2021 Mar 30", "meta_volume": "61", "meta_issue": "3", "meta_pages": "36-41", "score": 50244.492, "text_hl": "Psychological Continuum of Elderly @SPECIES_9606 @@@Patients@@@ Suffering from @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@Arterial Hypertension@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@, Against the Background of Chronotherapy with a Fixed Combination of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@.", "citations": {"NLM": "Agarkov NM, Okhotnikov OI, Korneeva SI, Moskaleva EO, Moskalev AA, Kolomiets VI, Markelova AM, Markelova EA. Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin. Kardiologiia. 2021 Mar 30;61(3):36-41. PMID: 33849417", "BibTeX": "@article{33849417, title={Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.}, author={Agarkov NM and Okhotnikov OI and Korneeva SI and Moskaleva EO and Moskalev AA and Kolomiets VI and Markelova AM and Markelova EA}, journal={Kardiologiia}, volume={61}, number={3}, pages={36-41}}"}}, {"_id": "19922631", "pmid": 19922631, "pmcid": "PMC2784465", "title": "The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition", "journal": "BMC Geriatr", "authors": ["Hajjar I", "Hart M", "Milberg W", "Novak V", "Lipsitz L"], "date": "2009-11-18T00:00:00Z", "doi": "10.1186/1471-2318-9-48", "meta_date_publication": "2009 Nov 18", "meta_volume": "9", "meta_issue": "", "meta_pages": "48", "score": 50046.258, "text_hl": "A total of 100 community eligible individuals (60 years or older) with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and early @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive impairment@@@ are being recruited from the greater Boston area and randomized to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@, or @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ (\"active control\") for 12 months. ", "citations": {"NLM": "Hajjar I, Hart M, Milberg W, Novak V, Lipsitz L. The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition BMC Geriatr. 2009 Nov 18;9():48. PMID: 19922631", "BibTeX": "@article{19922631, title={The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition}, author={Hajjar I and Hart M and Milberg W and Novak V and Lipsitz L}, journal={BMC Geriatr}, volume={9}, pages={48}}"}}, {"_id": "21516731", "pmid": 21516731, "title": "[Impact of antihypertensive therapy on clinical status and quality of life in patients with initial manifestations of hypertensive encephalopathy].", "journal": "Ter Arkh", "authors": ["Varakin IuIa", "Oshchepkova EV", "Gornostaeva GV", "Amintaeva AG", "Kadykov AV", "Kravchenko MA", "Prokopovich ME", "Manvelov LS", "Suslina ZA"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "82", "meta_issue": "12", "meta_pages": "10-5", "score": 50033.29, "text_hl": "All the @SPECIES_9606 @@@patients@@@ were observed to have @<m>DISEASE_Cognition_Disorders</m> @DISEASE_MESH:D003072 @@@cognitive dysfunctions@@@. ", "citations": {"NLM": "Varakin IuIa, Oshchepkova EV, Gornostaeva GV, Amintaeva AG, Kadykov AV, Kravchenko MA, Prokopovich ME, Manvelov LS, Suslina ZA. [Impact of antihypertensive therapy on clinical status and quality of life in patients with initial manifestations of hypertensive encephalopathy]. Ter Arkh. 2010;82(12):10-5. PMID: 21516731", "BibTeX": "@article{21516731, title={[Impact of antihypertensive therapy on clinical status and quality of life in patients with initial manifestations of hypertensive encephalopathy].}, author={Varakin IuIa and Oshchepkova EV and Gornostaeva GV and Amintaeva AG and Kadykov AV and Kravchenko MA and Prokopovich ME and Manvelov LS and Suslina ZA}, journal={Ter Arkh}, volume={82}, number={12}, pages={10-5}}"}}]}